01—Abstract
Summary
Summary of the 8-K filed May 5, 2026. Cited figures are marked; the original filing is the authoritative source.
Emerson Electric (NYSE: EMR) reported fiscal second quarter 2026 results (quarter ended March 31, 2026) that were mixed: net sales rose 3% to $4,562 milliona, but underlying sales grew only 0.5% and underlying orders grew 5%.
GAAP EPS increased 28% to $1.10b, while adjusted EPS rose 4% to $1.54. Pretax margin expanded sharply to 17.4% from 14.2%, largely because acquisition/divestiture costs fell from $168 million to $10 million and interest and other items were reshaped, while adjusted segment EBITA margin contracted 40 basis points to 27.6%. Management attributed the sales shortfall to the Middle East conflict and described margins as exceeding expectations.
The company updated its fiscal 2026 outlook, guiding to adjusted EPS of $6.45 to $6.55c (versus a prior framing not disclosed in this filing), net sales growth of about 4.5%, underlying sales growth of about 3%, and free cash flow of $3.5 to $3.6 billion. Management is pivoting capital allocation toward shareholder returns, planning roughly $2.2 billion in returns in 2026, including about $1 billion in share repurchases and $1.2 billion in dividends. The quarterly dividend was declared at $0.555 per share.
Balance sheet metrics show short-term borrowings rising to $5.8 billion and long-term debt falling to $7.6 billiond, and cash from operations fell 6% in the quarter, with free cash flow down 6% to $694 million. Separately, the board elected Jennifer G. Newstead, Apple's Senior Vice President and General Counsel and former Chief Legal Officer at Meta, as an independent director effective August 3, 2026, expanding the board to 11 members.
She will join the Compensation and Corporate Governance and Nominating Committees and receive a pro rata RSU award valued at $95,000. For investors, the key items are the strong orders trend and margin performance against weak underlying sales, the reliance on a strong second half, and the heavier shift toward shareholder returns funded partly by short-term borrowings.
02—Key points
Key Highlights
- Net sales rose 3% to $4,562 million, but underlying sales grew only 0.5%, with Asia, Middle East & Africa down 5% and Europe down 4%.
- Underlying orders grew 5%, led by Software & Systems, which management cited as evidence of resilient demand and a robust backlog.
- GAAP EPS rose 28% to $1.10 and adjusted EPS rose 4% to $1.54, with pretax margin up 320 bps to 17.4%, aided by lower acquisition and divestiture costs.
- Adjusted segment EBITA margin declined 40 bps to 27.6%, and Test & Measurement drove the underlying sales gain at 12% while Control Systems & Software declined 2%.
- FY2026 guidance calls for adjusted EPS of $6.45 to $6.55, underlying sales growth of about 3%, operating cash flow of $4.0 to $4.1 billion, and free cash flow of $3.5 to $3.6 billion.
- The company plans about $2.2 billion of shareholder returns in 2026 (about $1 billion in buybacks and $1.2 billion in dividends), with a quarterly dividend of $0.555 per share.
- Short-term borrowings increased to $5.8 billion from $4.8 billion at fiscal year-end, while long-term debt fell to $7.6 billion, and Q2 free cash flow declined 6% to $694 million.
03—Questions
Frequently Asked Questions
Why did GAAP EPS grow faster than adjusted EPS this quarter?
GAAP EPS rose 28% to $1.10 largely because acquisition and divestiture fees and related costs dropped from $168 million to $10 million, and interest expense was reshaped. Adjusted EPS, which excludes amortization, restructuring, acquisition costs, and discrete taxes, rose a more modest 4% to $1.54, reflecting underlying operating performance.
How much of the sales growth came from underlying business versus currency or acquisitions?
Reported net sales grew 3%, but currency contributed about 2.5 points of favorability and there were no acquisition or divestiture effects in the quarter. Underlying sales therefore grew only about 0.5%, with Test & Measurement (up 12%) offsetting declines in Control Systems & Software (down 2%) and Final Control (down 1%).
What is the outlook for the second half of fiscal 2026?
Management expects a strong second half supported by order momentum and backlog. For the third quarter, guidance calls for net sales growth of about 5.5%, underlying sales growth of about 5%, and adjusted EPS of $1.65 to $1.70. Full-year guidance implies a meaningful step-up from the first half, and the company expects to lower its effective amortization burden and manage restructuring costs at roughly $0.18 per share for the year.
Is Emerson funding its increased shareholder returns with debt?
Partly. The company plans about $2.2 billion of returns in 2026 against guided free cash flow of $3.5 to $3.6 billion. Short-term borrowings rose to $5.8 billion at March 31, 2026, from $4.8 billion at September 30, 2025, and the company repaid about $5.6 billion of longer-dated short-term borrowings during the first half, so investors should monitor leverage and refinancing needs.
What does the Jennifer Newstead board appointment mean for investors?
Newstead, currently Apple's General Counsel and formerly Meta's Chief Legal Officer, brings legal, regulatory, and governance expertise to Emerson's board. She is independent, will join the Compensation and Corporate Governance and Nominating Committees, and receives a $95,000 pro rata RSU award. The appointment is effective August 3, 2026, and expands the board to 11 members, which is a governance addition rather than a financial event.
04—Continue